Literature DB >> 3962935

Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia.

G R Buchanan, S J Smith.   

Abstract

Although polyvalent pneumococcal vaccine and prophylactic penicillin are used to prevent overwhelming Streptococcus pneumoniae septicemia in infants and young children with sickle cell anemia, infection rates remain high. We have reviewed our seven-year experience with a regimen of twice daily oral penicillin V potassium prophylaxis in 88 affected children. The median age at the start of prophylaxis was 10 months, and the median duration of prophylaxis was 29 months (range, three months to seven years). The total period of observation of patients who were prescribed penicillin was 248 person-years. Most patients also received one or two doses of polyvalent pneumococcal vaccine. Despite penicillin prophylaxis and pneumococcal vaccine, eight episodes of S pneumoniae septicemia have occurred and three have been fatal. Four episodes were in children older than 3 years. Suboptimal compliance with the prescribed oral penicillin regimen was usually apparent. With one possible exception, the infections occurred when penicillin had not been taken during the previous 24 hours. The S pneumoniae septicemia rate in this patient population, 3.2 per 100 person-years, is somewhat less than that described in previous reports of children not receiving penicillin but is still unacceptably high. Vigorous advocacy of a penicillin prophylaxis regimen does not eliminate the risk of pneumococcal septicema in this patient population.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3962935     DOI: 10.1001/archpedi.1986.02140190038020

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  17 in total

1.  Assessment of care of children with sickle cell disease: implications for neonatal screening programmes.

Authors:  R I Milne
Journal:  BMJ       Date:  1990-02-10

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Penicillin prophylaxis in children with sickle cell disease.

Authors:  Mary Petrea Cober; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

4.  Tumor necrosis factor alpha in children with sickle cell disease in stable condition.

Authors:  S Kuvibidila; R Gardner; D Ode; L Yu; G Lane; R P Warrier
Journal:  J Natl Med Assoc       Date:  1997-09       Impact factor: 1.798

5.  Canadian Immunization Guide.

Authors: 
Journal:  CMAJ       Date:  1989-08-01       Impact factor: 8.262

Review 6.  Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Authors:  Kathleen E Walsh; Sarah L Cutrona; Patricia L Kavanagh; Lori E Crosby; Chris Malone; Katie Lobner; David G Bundy
Journal:  Pediatrics       Date:  2014-11-17       Impact factor: 7.124

7.  Prevention and therapy of bacterial infections for children with asplenia or hyposplenia.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-09       Impact factor: 2.253

Review 8.  Prevention and management of infection in children with sickle cell anaemia.

Authors:  W Y Wong
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

9.  Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman.

Authors:  P J McElroy; F I Henderson; D L Brown
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 10.  Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.

Authors:  Kristin Loiselle; Jennifer L Lee; Lauren Szulczewski; Sarah Drake; Lori E Crosby; Ahna L H Pai
Journal:  J Pediatr Psychol       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.